149 related articles for article (PubMed ID: 8736633)
1. Effects of phencyclidine metabolites on serotonin uptake in rat brain.
Hori T; Suzuki T; Baba A; Abe S; Yamamoto T; Moroji T; Shiraishi H
Neurosci Lett; 1996 May; 209(3):153-6. PubMed ID: 8736633
[TBL] [Abstract][Full Text] [Related]
2. Effect of fluvoxamine on 5-hydroxytryptamine uptake, paroxetine binding sites and ketanserin binding sites in the Japanese monkey brain and platelets, in vivo and in vitro.
Goto S; Egashira T; Wada Y; Takayama F; Yamanaka Y
Jpn J Pharmacol; 1996 Aug; 71(4):291-8. PubMed ID: 8886926
[TBL] [Abstract][Full Text] [Related]
3. Effects of metaphit on phencyclidine and serotonin2 receptors.
Nabeshima T; Tohyama K; Noda A; Maeda Y; Hiramatsu M; Harrer SM; Kameyama T; Furukawa H; Jacobson AE; Rice KC
Neurosci Lett; 1989 Jul; 102(2-3):303-8. PubMed ID: 2554211
[TBL] [Abstract][Full Text] [Related]
4. Protection with phencyclidine against inactivation of 5-HT2 receptors by sulfhydryl-modifying reagents.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Biochem Pharmacol; 1988 Sep; 37(17):3277-83. PubMed ID: 3135811
[TBL] [Abstract][Full Text] [Related]
5. Potentiation in phencyclidine-induced serotonin-mediated behaviors after intracerebroventricular administration of 5,7-dihydroxytryptamine in rats.
Nabeshima T; Yamaguchi K; Ishikawa K; Furukawa H; Kameyama T
J Pharmacol Exp Ther; 1987 Dec; 243(3):1139-46. PubMed ID: 2826756
[TBL] [Abstract][Full Text] [Related]
6. Effects of the major metabolite of phencyclidine, the trans isomer of 4-phenyl-4-(1-piperidinyl)cyclohexanol, on [3H]N-(1-[2-thienyl] cyclohexyl)-3,4-piperidine ([3H]TCP) binding and [3H]dopamine uptake in the rat brain.
Baba A; Yamamoto T; Yamamoto H; Suzuki T; Moroji T
Neurosci Lett; 1994 Nov; 182(1):119-21. PubMed ID: 7891876
[TBL] [Abstract][Full Text] [Related]
7. Phencyclidine-induced head-twitch response in rats treated chronically with methysergide.
Nabeshima T; Ishikawa K; Yamaguchi K; Furukawa H; Kameyama T
Eur J Pharmacol; 1987 Jan; 133(3):319-28. PubMed ID: 3556394
[TBL] [Abstract][Full Text] [Related]
8. [3H]paroxetine binding in rat frontal cortex strongly correlates with [3H]5-HT uptake: effect of administration of various antidepressant treatments.
Cheetham SC; Viggers JA; Slater NA; Heal DJ; Buckett WR
Neuropharmacology; 1993 Aug; 32(8):737-43. PubMed ID: 8413837
[TBL] [Abstract][Full Text] [Related]
9. Effects of repeated phencyclidine treatment on serotonin transporter in rat brain.
Hori T; Abe S; Baba A; Suzuki T; Shiraishi H
Neurosci Lett; 2000 Feb; 280(1):53-6. PubMed ID: 10696810
[TBL] [Abstract][Full Text] [Related]
10. Phencyclidine-induced head-weaving and head-twitch through interaction with 5-HT1 and 5-HT2 receptors in reserpinized rats.
Yamaguchi K; Nabeshima T; Ishikawa K; Yoshida S; Kameyama T
Neuropharmacology; 1987 Oct; 26(10):1489-97. PubMed ID: 2446188
[TBL] [Abstract][Full Text] [Related]
11. Effects of chronic administration of interferon alpha A/D on serotonergic receptors in rat brain.
Abe S; Hori T; Suzuki T; Baba A; Shiraishi H; Yamamoto T
Neurochem Res; 1999 Mar; 24(3):359-63. PubMed ID: 10215509
[TBL] [Abstract][Full Text] [Related]
12. In vivo EEDQ dose-dependently inactivates rat brain 5-HT receptors but not 5-HT uptake sites.
Pinto W; Battaglia G
Neuroreport; 1993 Oct; 5(1):61-4. PubMed ID: 8280861
[TBL] [Abstract][Full Text] [Related]
13. Effects of experimental hypothyroidism on 5-HT1A, 5-HT2A receptors, 5-HT uptake sites and tryptophan hydroxylase activity in mature rat brain1.
Kulikov A; Moreau X; Jeanningros R
Neuroendocrinology; 1999 Jun; 69(6):453-9. PubMed ID: 10364698
[TBL] [Abstract][Full Text] [Related]
14. Selectivity of serotonergic drugs for multiple brain serotonin receptors. Role of [3H]-4-bromo-2,5-dimethoxyphenylisopropylamine ([3H]DOB), a 5-HT2 agonist radioligand.
Titeler M; Lyon RA; Davis KH; Glennon RA
Biochem Pharmacol; 1987 Oct; 36(19):3265-71. PubMed ID: 3663239
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic involvement in phencyclidine-induced behaviors.
Nabeshima T; Yamaguchi K; Hiramatsu M; Amano M; Furukawa H; Kameyama T
Pharmacol Biochem Behav; 1984 Sep; 21(3):401-8. PubMed ID: 6208563
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition.
El Mansari M; Blier P
J Psychiatry Neurosci; 2005 Jul; 30(4):268-74. PubMed ID: 16049570
[TBL] [Abstract][Full Text] [Related]
17. In vivo control of 5-hydroxytryptamine release by terminal autoreceptors in rat brain areas differentially innervated by the dorsal and median raphe nuclei.
Hervás I; Bel N; Fernández AG; Palacios JM; Artigas F
Naunyn Schmiedebergs Arch Pharmacol; 1998 Sep; 358(3):315-22. PubMed ID: 9774218
[TBL] [Abstract][Full Text] [Related]
18. Effects of 5,7-dihydroxytryptamine on serotonin1 and serotonin2 receptors throughout the rat central nervous system using quantitative autoradiography.
Fischette CT; Nock B; Renner K
Brain Res; 1987 Sep; 421(1-2):263-79. PubMed ID: 3690273
[TBL] [Abstract][Full Text] [Related]
19. Characterization of serotonin receptors and lack of effect of antidepressant therapy on monoamine functions in various regions of the rabbit brain.
Schoups A; Dillen L; Claeys M; Duchateau A; Verbeuren TJ; De Potter WP
Eur J Pharmacol; 1986 Jul; 126(3):259-71. PubMed ID: 3758172
[TBL] [Abstract][Full Text] [Related]
20. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
